50 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Cd44tm1Mak/Cd44tm1Mak Mettm1Cbm/Met+ involves: 129P2/OlaHsd * C57BL/6	abnormal miniature excitatory postsynaptic currents	J:128984
	abnormal miniature inhibitory postsynaptic currents	J:128984
	abnormal phrenic nerve morphology	J:128984
	decreased miniature inhibitory postsynaptic current frequency	J:128984
	lethality, incomplete penetrance	J:128984
	neonatal lethality, incomplete penetrance	J:128984
	primary atelectasis	J:128984
	respiratory distress	J:128984
Gab1tm1Wbm/Gab1tm1Wbm Mettm1Cbm/Mettm1Cbm involves: 129P2/OlaHsd * C57BL/6	hypaxial muscle hypoplasia	J:68751
Gab1tm3Wbm/Gab1tm3Wbm Mettm1Cbm/Met+ involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1	cleft secondary palate	J:125303
Mettm1Cpo/Met+ Pax3tm2.1(PAX3/FOXO1A)Buck/Pax3+ involves: 129 * BALB/c * C57BL/6	normal embryo phenotype	J:86911
Mettm1Cpo/Mettm1Cpo involves: 129S1/Sv * 129X1/SvJ	abnormal axon extension	J:174591
	abnormal neuron physiology	J:174591
	normal nervous system phenotype	J:174591
Mettm1Cpo/Mettm1Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6	absent skeletal muscle	J:98439
	normal muscle phenotype	J:98439
Mettm1Cpo/Mettm1Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal muscle development	J:36244
	abnormal tongue muscle morphology	J:36244
	absent diaphragm	J:36244
	decreased embryo size	J:36244
	lethality throughout fetal growth and development, complete penetrance	J:36244
	pale placenta	J:36244
	small placenta	J:36244
Mettm1Cpo/Mettm1Cpo Pax3tm2.1(PAX3/FOXO1A)Buck/Pax3+ involves: 129 * BALB/c * C57BL/6	normal embryo phenotype	J:86911
Mettm1Cpo/Mettm1Sst Tg(Nes-cre)1Kln/? involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL	normal vision/eye phenotype	J:173661
Mettm1Cpo/Mettm1Sst Tg(Nes-cre)1Kln/0 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	abnormal motor neuron innervation pattern	J:174591
	abnormal neuromuscular synapse morphology	J:174591
	decreased motor neuron number	J:174591
	impaired coordination	J:174591
Mettm1Cpo/Mettm2Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	decreased skeletal muscle mass	J:36244
	neonatal lethality, complete penetrance	J:36244
	respiratory failure	J:36244
Mettm1Gvw/Met+ involves: 129 * C57BL/6J	chromosome breakage	J:94722
	glomerulonephritis	J:94722
	hydronephrosis	J:94722
	increased carcinoma incidence	J:94722
	increased histiocytic sarcoma incidence	J:94722
	increased lymphoma incidence	J:94722
	increased squamous cell carcinoma incidence	J:94722
	increased tumor incidence	J:94722
Mettm1Gvw/Mettm1Gvw involves: 129 * C57BL/6J	embryonic lethality between implantation and somite formation, complete penetrance	J:94722
Mettm1Ics/Mettm1Sst Tg(Nes-cre)1Kln/0 involves: 129P2/OlaHsd * C57BL/6 * SJL	decreased motor neuron number	J:174591
Mettm1Sst/Mettm1Sst Trp53tm1Brn/Trp53tm1Brn involves: 129P2/OlaHsd	normal cellular phenotype	J:175978
Mettm1Sst/Mettm1Sst Trp53tm1Brn/Trp53tm2Tyj involves: 129P2/OlaHsd * 129S4/SvJae	normal cellular phenotype	J:175978
Mettm1Sst/Mettm1Sst Trp53tm1Brn/Trp53tm3Tyj involves: 129P2/OlaHsd * 129S4/SvJae	normal cellular phenotype	J:175978
Mettm2Cpo/Mettm2Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal forelimb morphology	J:36244
	decreased skeletal muscle mass	J:36244
	neonatal lethality, complete penetrance	J:36244
	paraparesis	J:36244
	postnatal growth retardation	J:36244
Mettm2Cpo/Mettm4.1Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal neuron differentiation	J:81793
	impaired coordination	J:81793
	reduced cerebellar foliation	J:81793
	small cerebellum	J:81793
Mettm2Gvw/Met+ involves: 129 * C57BL/6J	chromosome breakage	J:94722
	glomerulonephritis	J:94722
	hydronephrosis	J:94722
	increased hemangiosarcoma incidence	J:94722
	increased histiocytic sarcoma incidence	J:94722
	increased lymphoma incidence	J:94722
	increased tumor incidence	J:94722
	premature death	J:94722
Mettm2Gvw/Mettm2Gvw involves: 129 * C57BL/6J	embryonic lethality between implantation and somite formation, complete penetrance	J:94722
Mettm3Cpo/Mettm3Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	no abnormal phenotype detected	J:36244
Mettm3Gvw/Mettm3Gvw involves: 129 * C57BL/6J	chromosome breakage	J:94722
	increased hemangiosarcoma incidence	J:94722
	increased tumor incidence	J:94722
	premature death	J:94722
Mettm4Cpo/Mettm2Cpo involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal forelimb morphology	J:81793
	neonatal lethality, complete penetrance	J:81793